{
    "nctId": "NCT02438449",
    "briefTitle": "Cost-Effectiveness of Abdominal-based Autogenous Tissue vs Tissue Expander-Implant Reconstruction - A Feasibility Study",
    "officialTitle": "A Cost-Effectiveness Analysis Comparing Abdominal-based Autogenous Tissue (AAT) and Tissue Expander- Implant (TE/I) Reconstruction of the Breast After Mastectomy- A Feasibility Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 61,
    "primaryOutcomeMeasure": "Health-related Quality of Life (utilities and disease-specific)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Patients 18 years of age or older.\n2. Patients undergoing breast reconstruction (immediate or delayed) after mastectomy procedure on one or both breasts.\n3. Eligible for two step tissue expander and implant based procedure, or one of the following autogenous abdomen tissue-based procedures (pedicled TRAM flap, Free TRAM, ms TRAM flap, DIEP flap, SIEA flap, Rubens flap).\n\nExclusion Criteria:\n\n1. Patients who have had previous breast reconstruction surgery.\n2. Patients undergoing other procedures during reconstruction surgery, other than the mastectomy itself in the case of immediate or delayed reconstruction.\n3. Patients unable to complete the questionnaires due to language barriers.\n4. Geographic inaccessibility or inability to adhere to study protocol requirements.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}